Actionable news
All posts from Actionable news
Actionable news in IMGN: ImmunoGen, Inc.,

ImmunoGen, Inc.

Investment OutlookImmunoGen, Inc. has a fundamental score of 13 and has a relative valuation of NEUTRAL. ImmunoGen, Inc. is on the bottom right quadrant of CapitalCube's Value - Price Matrix. We therefore classify ImmunoGen, Inc. as 'Speculative'. In other words, not only is ImmunoGen, Inc.'s Fundamental Analysis Score low at 13, but it is also potentially overvalued, in that it trades at a price higher than its CapitalCube Implied Price of 3.99.SpreadsheetImmunoGen, Inc. is currently neutrally valued, as its previous close of USD 5.61 lies within the CapitalCube estimate range of USD 2.36 to USD 5.63. Over the last 52...